Works matching IS 17562856 AND DT 2017 AND VI 10 AND IP 9

Results: 3
    1

    Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China.

    Published in:
    Therapeutic Advances in Neurological Disorders, 2017, v. 10, n. 9, p. 315, doi. 10.1177/1756285617721092
    By:
    • Zhou, Lei;
    • Liu, Weibin;
    • Li, Wei;
    • Li, Haifeng;
    • Zhang, Xu;
    • Shang, Huifang;
    • Bu, Bitao;
    • Deng, Hui;
    • Fang, Qi;
    • Li, Jimei;
    • Zhang, Hua;
    • Song, Zhi;
    • Ou, Changyi;
    • Yan, Chuanzhu;
    • Liu, Tao;
    • Zhou, Hongyu;
    • Bao, Jianhong;
    • Lu, Jiahong;
    • Shi, Huawei;
    • Zhao, Chongbo
    Publication type:
    Article
    2

    Edaravone: a baby in the bathwater?

    Published in:
    Therapeutic Advances in Neurological Disorders, 2017, v. 10, n. 9, p. 313, doi. 10.1177/1756285617720351
    By:
    • Ludolph, Albert
    Publication type:
    Article
    3